News & Press Releases
Baron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved UsesBaron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved Uses
Baron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved Uses
Pharmaceutical Company Allegedly Violated Federal and Texas Medicaid Laws August 01, 2018 DALLAS--(BUSINESS WIRE)--Today, the national law firm of Baron & Budd announced that Endo Pharmaceuticals Inc. (“Endo”) [...]
Baron & Budd Secures Three Additional Settlements with Virginia Defense Contractors for Alleged FCA Violations Totaling $620,000
Washington, D.C. - The national law firm of Baron & Budd today announced that the U.S. Department of Justice has reached settlements with three additional [...]
Baron & Budd Wins School Bus Whistleblower Case, Keeps San Francisco Children Safe
Employees Help End Shocking Maintenance Practices that Endangered Students SAN FRANCISCO (May 25, 2016) –The national law firm of Baron & Budd recently secured an [...]
Harassment, Shocking Disregard for Student Safety Highlight San Francisco Whistleblower Case
Whether you have children or not, this story involving a whistleblower case in San Francisco should have your blood boiling. Thankfully, it has a good [...]
